Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    This update reflects a change in the ClinicalTrials.gov page revision/version number from v3.5.2 to v3.5.3, indicating a site release rather than a modification to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:02.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:52.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added site revision tag v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:34:44.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:03:56.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The site version was updated to Revision: v3.4.2 and an older government funding status notice was removed, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:15.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations was added, and the page shows a version update from v3.4.0 to v3.4.1. These updates do not alter the trial details or data presented.
    Difference
    0.4%
    Check dated 2026-02-04T05:22:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.